December 26, 2014 10:29 PM ET

Pharmaceuticals

Company Overview of Vicuron Pharmaceuticals, Inc.

Company Overview

Vicuron Pharmaceuticals, Inc., a biopharmaceutical company, offers discovery, development, manufacture, and marketing of antibiotic drugs. The company’s products include Dalbavancin, a long-acting, injectable, lipoglycopeptide antibiotic in late-stage clinical development. Dalbavancin offers activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The company’s products also include ramoplanin, which is an oral nonabsorbable form of antibiotic that selectively inhibits Gram-positive bacteria, and various types of vancomycin-resistant enterococci and Clostridia. In addition, it provides VIC-Acne, a topical antibiotic cream that is in Phase I clini...

455 South Gulph Road

Suite 305

King of Prussia, PA 19406

United States

Founded in 1995

216 Employees

Phone:

610-205-2300

Fax:

610-205-2350

Key Executives for Vicuron Pharmaceuticals, Inc.

Chief Executive Officer
Age: 58
Chief Operating Officer
Age: 49
Chief Manufacturing Officer
Age: 71
Chief Medical Officer
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cytos Pharmaceuticals L.L.C. United States
Lab Amazon Group, Inc. United States
Aerovance, Inc. United States
CG Nutritionals, Inc. United States
Housey Pharmaceutical Research Laboratories LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vicuron Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.